Skip to main content
. 2011 Nov 21;11:489. doi: 10.1186/1471-2407-11-489

Figure 1.

Figure 1

GPS was an independent poor prognostic factor for OS in recurred or metastatic gastric cancer patients receiving first-line palliative chemotherapy (GPS = 1, HR 1.75 95% CI 1.37-2.26, P = 0.001; GPS = 2, HR 1.79, 95% CI 1.29-2.47, P = 0.001).